Marcus Ruscetti to Proto-Oncogene Proteins p21(ras)
This is a "connection" page, showing publications Marcus Ruscetti has written about Proto-Oncogene Proteins p21(ras).
Connection Strength
0.483
-
Qiao Y, Yee MF, Parikh CN, Ma B, Cao Y, Shih YH, Wu JQ, Ruscetti M, Liang SQ, Xue W. KRAS Withdrawal in Cholangiocarcinoma Leads to Immune Infiltration and Tumor Regression. Adv Sci (Weinh). 2026 Jan; 13(6):e11312.
Score: 0.228
-
Ruscetti M, Leibold J, Bott MJ, Fennell M, Kulick A, Salgado NR, Chen CC, Ho YJ, Sanchez-Rivera FJ, Feucht J, Baslan T, Tian S, Chen HA, Romesser PB, Poirier JT, Rudin CM, de Stanchina E, Manchado E, Sherr CJ, Lowe SW. NK cell-mediated cytotoxicity contributes to tumor control by a cytostatic drug combination. Science. 2018 12 21; 362(6421):1416-1422.
Score: 0.141
-
Ruscetti M, Dadashian EL, Guo W, Quach B, Mulholland DJ, Park JW, Tran LM, Kobayashi N, Bianchi-Frias D, Xing Y, Nelson PS, Wu H. HDAC inhibition impedes epithelial-mesenchymal plasticity and suppresses metastatic, castration-resistant prostate cancer. Oncogene. 2016 07 21; 35(29):3781-95.
Score: 0.114